Related Experiment Video
Updated: Mar 17, 2026
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
3H-Penciclovir (3H-PCV) Uptake Assay
Thillai V Sekar1, Ramasamy Paulmurugan1
1Department of Radiology, Stanford University School of Medicine, Palo Alto, USA.
Abstract:
Thymidine Kinase from human Herpes simplex virus type 1 (HSV1-TK) in combination with specific substrate prodrug nucleotide analogue ganciclovir (GCV) has been widely used as suicidal therapeutic gene for cancer gene therapy. HSV1, and its mutant (HSV1-sr39TK) with improved substrate specificity, were used as reporter genes for PET-imaging of various biological functions in small animals, by combining with radiolabeled substrates such as 18F-FHBG and 124I-FIAU. 3H-Penciclovir (PCV) uptake assay is a method of choice used to determine the expression level of HSV1-TK in mammalian cells and tissues. HSV1-TK phosphorylate PCV and result in the formation of penciclovir monophosphate, and its subsequent phopsphorylation by cellular TK lead to the formation of penciclovir triphosphate, which is trapped selectively in cells expressing HSV-TK. 3H-Penciclovir enables the detection of penciclovir uptake of mammalian cells and tissues by radioactive procedures such as scintillation counting. Here we describe the protocol to carry out 3H-Penciclovir uptakes in mammalian cells.
Insights
This study details a protocol for measuring 3H-Penciclovir uptake in mammalian cells. This method quantifies the expression of Herpes simplex virus type 1 thymidine kinase (HSV1-TK), crucial for cancer gene therapy and PET imaging.
Area of Science:
- Molecular Biology
- Biotechnology
- Cancer Research
Background:
- Herpes simplex virus type 1 thymidine kinase (HSV1-TK) is a key enzyme in cancer gene therapy and reporter gene imaging.
- HSV1-TK, along with its mutant HSV1-sr39TK, facilitates PET imaging using radiolabeled substrates.
- Quantifying HSV1-TK expression is essential for evaluating therapeutic efficacy and imaging sensitivity.
Purpose of the Study:
- To provide a detailed protocol for the 3H-Penciclovir (PCV) uptake assay in mammalian cells.
- To establish a reliable method for determining HSV1-TK expression levels.
- To support applications in cancer gene therapy and biological imaging.
Main Methods:
- Utilizing radiolabeled 3H-Penciclovir (PCV) as a substrate for HSV1-TK.
- Measuring the intracellular trapping of phosphorylated PCV, indicative of HSV1-TK activity.
- Employing radioactive detection methods, such as scintillation counting, for quantification.
Main Results:
- The protocol enables sensitive detection of PCV phosphorylation and subsequent trapping by HSV1-TK.
- Quantifiable uptake of 3H-PCV correlates with HSV1-TK expression levels in cells and tissues.
- The method provides a direct measure of functional HSV1-TK activity.
Conclusions:
- The described 3H-Penciclovir uptake assay is a valuable tool for assessing HSV1-TK expression.
- This protocol facilitates research in cancer gene therapy and in vivo imaging applications.
- Accurate quantification of HSV1-TK is critical for advancing these therapeutic and diagnostic strategies.
